Vanguard Capital Management
ZYME icon

Vanguard Capital Management’s Zymeworks ZYME Stock Holding History

Vanguard Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.8M Sell
1,558,998
-146,582
-9% -$3.72M ﹤0.01% 2062
2026
Q1 		$42.7M Buy
+1,705,580
New +$40.4M ﹤0.01% 1941

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management's ZYME Position: Q2 2026 in Review

Vanguard Capital Management reduced its Zymeworks (ZYME) stake by 8.6% in Q2 2026, selling an estimated $3.72M and leaving 1,558,998 shares worth $40.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2062.

Vanguard Capital Management first reported a position in ZYME in Q1 2026 and has held it in 2 quarters since. The position peaked at $42.7M in Q1 2026. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Vanguard Capital Management held 1,558,998 shares of Zymeworks worth $40.8M as of Q2 2026.
  • Vanguard Capital Management sold 146,582 Zymeworks shares in Q2 2026, an estimated $3.72M.
  • Zymeworks made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2062 holding.
  • Vanguard Capital Management first reported a position in Zymeworks in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Zymeworks position peaked at $42.7M in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.